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SUMMARY – Background: This report describes data collected by the Croatian Registry of Renal 
Biopsies (CRRB) for the year 2019. Patients and methods: nine centers (82%) provided data for 255 
native kidney biopsies. We  assessed the anthropometric data, data on serum creatinine concentration 
(sCr), 24 h proteinuria, haematuria, serum albumin level, arterial hypertension, histological diagnosis, 
and complications after renal biopsy. Results: examined group consisted of 58% males, median age 58 
y (18-80 y) and 42% women, median age 57 y (20-86 y). Males had a more impaired renal function at 
the time of renal biopsy,  nephrotic syndrome, and hypertension. The most prevalent clinical presenta-
tion were urinary abnormalities (34.9%). Among all biopsy cases, primary glomerular diseases were 
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the most often found histology group (41.5%), and IgA nephropathy was the most frequent diagno-
sis(47.1%). Among  secondary glomerular diseases, pauci-immune glomerulonephritis (PIGN) was 
most often found (30.9%). The highest proteinuria was observed in minimal change disease and dia-
betic nephropathy (DN). The highest sCR values were found in membranoproliferative glomerulone-
phritis (MPGN) and necrotizing vasculitis. Patients with MPGN and DN had the highest blood 
pressure levels. Conclusion: CRRB provides important data on the epidemiology of biopsy-proven 
kidney diseases from the whole territory of Croatia
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Introduction
One of the key features for the development of qual-
ity clinical, epidemiologic research has been identified 
in the development of databases or registries for the col-
lection of epidemiologic data related to specific disease1. 
Glomerulonephritis (GN) is a relatively rare disease, 
and most nephrology centers see only a limited number 
of patients with each type of GN every year.
Current epidemiological data of renal disease in 
Europe are available from large national renal biopsy 
registries2-5. Incidence and prevalence of glomerular 
diseases vary according to geographical location, gen-
der, age, and race. Therefore, establishing a national 
registry is of utmost importance, giving us the oppor-
tunity to learn more about the epidemiology of glo-
merular diseases in our country.
Until recently, the epidemiological data on the in-
cidence of kidney disease in the Croatian population 
were mostly based on reports of Croatian Institut of 
Public Health or Renal Replacement Registry of Cro-
atian Society of Nephrology, Dialysis and Transplan-
tation (CSNDT) and data providing histopathology 
results of kidney biopsy were sporadically reported as 
single-center reports6.
The nationwide Croatian Registry of Renal Biop-
sies (CRRB) was founded in 2019 after the initiative 
of CSNDT and included nine nephrology centers that 
reported clinical, laboratory and histopathological data 
of adult patients who underwent native kidney biopsy 
for the first time on a national level.
The aim of this study was to report on the relative 
frequency of nephropathies according to gender, age, 
clinical presentation, and renal function at the time of 
renal biopsy based on the histologic diagnosis.
Patients and methods
Renal biopsy records were collected during the pe-
riod from January 1st till December 31st, 2019. Nine 
renal centers out of eleven (82%) have participated. 
Using a simple questionnaire, the following data were 
collected at the time of renal biopsy: age, gender, an-
thropometric data, serum creatinine concentration 
(sCr), eGFR according to CKD EPI formula, 24-h 
proteinuria (UP), the presence of microscopic or mac-
roscopic hematuria (H), blood pressure (BP) values 
and the presence of arterial hypertension defined as 
blood pressure >140/90 mmHg or treatment with an-
tihypertensive drugs, clinical and histological diagno-
sis, clinical complications after renal biopsy (clinically 
symptomatic subcapsular or perirenal hematoma, gross 
hematuria and need for blood transfusion).
The following clinical syndromes were assessed at 
the time of renal biopsy: nephrotic syndrome protein-
uria >3.5 g/24 h, hyperlipidemia, edema); urinary ab-
normalities: persistent lowgrade proteinuria (<3.5 g/24 
h) with or without microhaematuria; nephritic syn-
drome (a combination of hematuria, hypertension and 
acute reduction of renal function, sCr > 110 µmol/l); 
rapidly progressive GN (progressive decline in renal 
function, hematuria, hypertension), advanced renal 
insufficiency(sCr >200 µmol/l with or without hema-
turia and proteinuria). We retrospectively analyzed the 
distribution of renal diseases according to clinical syn-
dromes, and therefore more than one clinical syn-
drome could be found in some patients. The indica-
tions for renal biopsy varied among centers according 
to local practice. Histological evaluation by light mi-
croscopy and immunofluorescence was performed 
routinely in all patients combined with electron mi-
croscopy in a substantial number of cases. Histological 
diagnosis were mainly based on WHO recommenda-
tions modified by others as follows: (1) Primary GN: 
minimal change disease (MCD), focal segmental glo-
merulosclerosis (FSGS), membranous nephropathy 
(MGN), IgA nephropathy (IgAN), C3 membranop-
roliferative GN (C3MPGN), (2) Secondary GN: sys-
temic lupus erythematosus (SLE), Henoch–Schonlein 
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purpura (HSP), pauci-immune GN (PIGN; Good-
pasture’s syndrome (GPS); renal amyloidosis (AM), 
light-chain deposit disease (LCDD), myeloma cast 
nephropathy (MCN) essential mixed cryoglobuline-
mia; GN associated with infectious diseases (non-
streptococcal GN, endocarditis, shunt GN and oth-
ers); diabetic nephropathy (DN); hereditary nephrop-
athies, i.e., Alport syndrome (AS), Fabry disease, 
thin basement membrane glomerulopathy (TBMN)3. 
Acute and chronic tubulointerstitial nephritis (TIN) 
and acute tubular injury (ATI)4. Vascular diseases in-
cluding benign and malignant nephroangiosclerosis 
(NAS), hemolytic–uraemic syndrome and thrombotic 
thrombocytopenic purpura (HUS/TTP), renal sclero-
derma, and cortical necrosis5. Others, including end-
stage renal disease (ESRD) of undetermined cause, 
unclassified nephropathies2,4,7,8. Ultrasound needle 
guidance was used most commonly except in 5 cases 
(1.9%) where CT guidance was performed.
Statistical analysis
Parameters are expressed as percentages or mean 
values ± standard deviation. A Chi-square test or Fish-
er exact test was used for categorical data according to 
simple size. A two-tailed t-test was used for continu-
ous variables. P<0.05 was considered statistically sig-
nificant. Statistical analyses were performed using 
STATISTICA, vers.8 (StatSoft, Inc).
Results
During the observed period of one year, data for 
255 native kidney biopsies were recorded. Examined 
group consisted of 58% males median age 58 years 
(range 18-80 years), and 42% females, median age 57 
years (range 20-86 years). Characteristics of renal bi-
opsy cases according to gender are shown in Table 1.
Males presented more often (72.2%) with renal 
impairment and with higher sCr in the time of renal 
biopsy (235 ±186 vs. 168±162 µmol/l, p=0.002). There 
was no significant difference between proteinuria 
(3.69+ vs. 2.94 g/dU) and blood pressure values 
(140/83 vs. 138/82 mmHg) compared to females. 
Clinical syndromes recorded at the time of renal bi-
opsy are shown in figure 1.
The most prevalent diagnosis in UA was IgA ne-
phropathy (29.1%), FSGS (14.5%), and nephroangio-
sclerosis (12.5%); in the nephrotic syndrome group, 
MN was most often diagnosed (25.8%), then DN 
(17.2%) and FSGS (15.5%); nephritic syndrome was a 
presentation of IgA nephropathy in 31% of cases, SLE 
nephritis in 13.7% and MPGN 10.3%. Patients with 
RPGN were the oldest, the average age was 63 years 
old, and the highest percentage of males (76%) were 
found. The most prevalent diagnosis in that group was 
PIGN (64%). In the group with advanced renal insuf-
ficiency with or without hematuria and proteinuria 
most prevalent diagnosis was nephroangiosclerosis 
(21.9%) and DN (17.1%). The youngest patients were 
found in the UA group (50 years). 11.7% of patients 
had the overlap of two or more clinical syndromes.
Among all biopsy cases, primary glomerular dis-
eases were the most often found histology group 
(41.5%), then secondary glomerular diseases (32.9%), 
vascular diseases (10.9%), and tubulointerstitial ne-
phritis (7.1%). Ten most common renal biopsy diag-
noses (more than 10 cases or above 5% during the ob-
served period) in our population are listed in figure 2.
The most frequent diagnosis among primary glo-
merular diseases was IgA nephropathy (47.1%), FSGS 
(25.4%), and membranous nephropathy (19.8%). In 
comparison, among secondary glomerular diseases, 
PIGN was found in 30.9% of cases, DN in 23.8%, and 
Table 1. Characteristics of renal biopsy cases in the whole 
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lupus nephritis in 17.8%. Nephroangiosclerosis were 
found in 92.8% of cases among vascular causes. The 
epidemiology and clinical characteristics of selected 
glomerulopathies and TIN at the time of renal biopsy 
are shown in table 2.
Among primary GN highest proteinuria was found 
in MCD (11.1 + 6.3 g/dU), MN (6.4+4.1 g/dU) and 
MPGN (3.9+1.4 g/dU). DN manifested with the 
highest proteinuria between secondary forms of GN. 
The highest levels of serum creatinine were found in 
patients with MPGN (183.1+123.6 µmol/l) in pri-
mary forms of PG, in secondary GN in PIGN 
(362.2+314.3 µmol/l) and in TIN (441.7 +181.9 
µmol/l). The highest blood pressure values were ob-
served in MPGN (154/92 mmHg) and DN (152/85 
mmHg).
Table 2. The epidemiology and clinical characteristics of most common renal biopsy diagnosis in the time of renal biopsy
























































































































Legend: IgA – IgA nephropathy, FSGS – focal segmental glomerulosclerosis, MN – membranous nephropathy, PIGN – pauci-immune 
glomerulonephritis, DN – diabetic nephropathy, SLE – lupus nephritis, TIN- tubulointerstitial nephritis, NS – nephroangiosclerosis; RI 
– renal insufficiency; NS – nephrotic syndrome
Figure 1. Clinical syndromes recorded at the time of renal 
biopsy
Legend: UA – urinary abnormalities, RI+/-UA – renal insufficiency 
with or without hematuria and proteinuria; RPGN – rapidly pro-
gressive GN
Figure 2. Most common renal biopsy diagnosis  
in the adult population
Legend: IgA – IgA nephropathy, FSGS – focal segmental glome-
rulosclerosis, PIGN – pauci-immune glomerulonephritis, NS – 
nephroangiosclerosis, MN – membranous nephropathy, DN – dia-
betic nephropathy, SLE – lupus nephritis, TIN- tubulointerstitial 
nephritis
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We analyzed the geographical distribution of pri-
mary glomerular diseases in Croatia according to con-
tinental and Mediterranean parts (figure 3). There 
were no significant differences in the frequency of sub-
types of primary glomerular diseases. Although not 
statistically significant, the comparison of particular 
subtypes revealed the higher creatinine levels in IgA 
nephropathy in the Mediterranean region compared 
to IgA nephropathy in the continental part of Croatia 
(143.3+181.1 vs. 209.3+182.8 µmol/l p=0.073). Simi-
lar observation was found for FSGS (100.6+56.9 vs 
139.2+56.6 p=0.09). Higher proteinuria levels were 
found in MN diagnosed in the Mediterranean part of 
the country (5.62+4.5 vs. 7.81+3.4 p=0.263). Further 
analysis of four geographical regions (central Croatia, 
west Croatia, Slavonia and Baranja, and Dalmatia) 
showed similar results regarding the frequency of pri-
mary glomerular disease subtypes.
In our group, we found almost 30% of patients 
older than 65 years. Average sCr was 264.4 µmol/l, 
proteinuria 3.46 g/dU, blood pressure 143/81 mmHg. 
Secondary GN was the most prevalent (37.3%) form 
of the disease, then primary GN (30.6%) and TIN 
(13.3%). PIGN was found in 17.3% of cases, MN and 
nephroangiosclerosis in 12%.
Patients younger than 65 years had average sCr 183 
µmol/l, proteinuria 3.34 g/dU, blood pressure 137/83 
mmHg. Primary GN was most often found (45%), 
and IgA nephropathy was the most prevalent diagno-
sis (23%), then FSGS (11%), MN, and nephroangio-
sclerosis (9.5%).
The frequency of serious complications (symptom-
atic hematoma, gross haematuria, need for blood trans-
fusion) was observed in 14 cases (5.8%). Forty-two of 
them had renal impairment, and 71% had hypertension.
Discussion
This study provides information about demograph-
ics, clinical presentation, and frequency of renal disease 
diagnosed by renal biopsy in the year 2019, covering 
population on the national level.
Figure 3. Geographical distribution of primary glomerular diseases between the continental and Mediterranean part of 
Croatia
Legend: IgA – IgA nephropathy, FSGS – focal segmental glomerulosclerosis, MN – membranous nephropathy MPG – membranopro-
liferative GN, MCD – minimal change disease
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Male gender was associated most frequently with 
most diagnostic categories (table 2), except SLE ne-
phritis being more frequent among females. Clinical 
presentation was more severe in the male population. 
Males had significantly higher SCr values at the time of 
renal biopsy than females and were more hypertensive 
(table 1). Other authors report similar observations3,4,5.
The most prevalent indication for renal biopsy was 
urinary abnormalities (37%) and nephrotic syndrome 
(23%). Similar indications were found in the Italian 
registry, while in other registries, slightly different re-
sults were found, the nephrotic syndrome was the 
leading indication (up to 53%) and then urinary ab-
normalities (up to 38%)2,3, 4,9.
In the group of patients presented with UA and 
nephritic syndrome, the most prevalent diagnosis was 
IgA nephropathy, and in the group with advanced re-
nal insufficiency, PIGN was most often found, which 
is similar to others (2,4). In the nephrotic syndrome 
group, MN was most often diagnosed, which is similar 
to the Italian registry, while in the Czech and Polish 
registries, MCD was the leading diagnose2-4.
Our report showed that primary and secondary 
GN were most often found in our patients who under-
went renal biopsy and comprised almost 75% of pa-
tients. IgA nephropathy was the most prevalent form 
of primary GN occurring in around 20% of patients, 
which is the same as findings of Czech and Polish reg-
istry2,4. PIGN was the most prevalent diagnosis found 
in the group of secondary GN. The most common di-
agnosis found in our population besides IgA nephrop-
athy and PIGN were FSGS and nephroangiosclerosis, 
which is similar to the finding of Czech registry2. The 
distribution pattern of primary GN diagnosis also cor-
responded to other European series10.
Among those with nephrotic proteinuria highest 
values were observed in patients with MCD and MN. 
If we compare results for primary GN, similar results 
were found in Czech, Polish, Italian and French regis-
try2-4,11. Among patients with secondary GN and ne-
phrotic proteinuria, DN was the most frequent diag-
nosis (65%).
The highest sCr values at presentation were ob-
served in patients with TIN and PIGN being almost 
all diagnosed with renal insufficiency (almost 100%) at 
the time of renal biopsy, which is in accordance with 
others (4). Renal insufficiency among primary GN s 
was highest in patients with MPGN and IgAN.
The overall prevalence of hypertension in our group 
was 47%. According to subgroup analysis, the highest 
frequency of hypertension was found in patients with 
DN (60%), and among patients with primary GN, hy-
pertension was most often found in MN (57%). Similar 
findings but even higher values were found in other reg-
istries, up to 71% in MN and 91% in patients with DN2,4.
Different pathology was observed in patients > 65 
years. We found secondary GN more often than pri-
mary GN, which is similar to others. We found PIGN 
as the most prevalent diagnosis, followed by MN and 
nephroangiosclerosis. This result is slightly different 
compared to others where MN, DN, and amyloidosis 
or nephroangiosclerosis are the most prevalent find-
ings in the older population2-5.
The geographical distribution of primary glomeru-
lar diseases according to continental and Mediterra-
nean parts (figure 3) was similar when we analyze the 
frequency of subtypes of primary glomerular diseases. 
However, a lower incidence of IgAN and higher inci-
dence of FSGS and MN were found in the Mediter-
ranean part. However, when we compare particular 
subtypes, we found, although not statistically signifi-
cant, worse clinical presentation, lower renal function 
in IgA nephropathy and FSGS, and higher proteinuria 
in MN in the Mediterranean region compared to the 
continental part of Croatia. Whether this has some 
meaning is yet to be determined by follow-up of these 
patients and on a larger study sample.
In conclusion, the results of CRRB, which include 
renal biopsies of the native kidneys performed in al-
most all Croatian renal biopsy centers, represent an 
important contribution to the epidemiology of renal 
diseases in Croatia. Our results showed that the epide-
miology of renal disease, mainly primary and second-
ary GN are similar to the results of surrounding coun-
tries in the region. We believe that the availability of 
these data will be a valuable source to nephrologists to 
stimulate further research and encourage work on the 
national biopsy register.
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Uvod: izvještaj opisuje podatke Hrvatskog registra biopsija nativnih bubrega za 2019.godinu. Ispitanici i metode: poslani 
su podaci za 255 biopsija nativnih bubrega. Evidentirana je dob, spol, antropometrijski podaci, serumski kreatinin, 24h pro-
teinurija, eGFR, prisutnost eritrociturije, arterijski tlak, klinička prezentacija, histološka slika i komplikacije biopsije bubrega. 
Rezultati: ispitivanu grupu činilo je 58% muškaraca, medijan dobi 58 g (18-80 g) i 42% žena, medijan dobi 57 g(20-86 g). 
Muškarci su se češće prezentirali azotemijom u času biopsije (67,5 %), nefrotskim sindromom (55,7 %) i hipertenzijom 
(62,5 %). Najčešće klinička prezentacija zbog koje je učinjena biopsija bubrega bio je sindrom eritrociturije i proteinurije 
(34,9 %). Najčešća skupina bubrežnih bolesti su bile primarne glomerulopatije (41,5 %). Među primarnim glomerularnim 
bolestima najučestalija je IgA nefropatija (IgAN)(47,1 %), a među sekundarnim glomerulonefritisima pauci imuni glomeru-
lonefritis (PIGN) (30,9 %). Najvišom proteinurijom manifestirali su se od primarnih glomerularnih bolesti bolest minimal-
nih promjena a od sekundarnih formi dijabetička nefropatija (DN). Najvišim vrijednostima kreatinina u času biopsije mani-
festirali su se MPGN i PIGN. Hipertenzija je bila najviša kod MPGN i DN. Učestalost ozbiljnih komplikacija zabilježena 
je u 14 bolesnika (5,8 %). Zaključak: rezultati ukazuju na važne epidemiološke podatke prikupljene iz reprezentativnog broja 
nefroloških centara s cijelog teritorija Republike Hrvatske.
Ključne riječi: registar, biopsija bubrega, glomerularne bolesti, epidemiologija

